Nordea Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,067
| Closed | -$489K | – | 867 |
|
|
2025
Q1 | $489K | Buy |
2,067
+6
| +0.3% | +$1.42K | ﹤0.01% | 860 |
|
|
2024
Q4 | $679K | Hold |
2,061
| – | – | ﹤0.01% | 852 |
|
|
2024
Q3 | $684K | Sell |
2,061
-3,958
| -66% | -$1.31M | ﹤0.01% | 860 |
|
|
2024
Q2 | $1.65M | Sell |
6,019
-291
| -5% | -$79.7K | ﹤0.01% | 725 |
|
|
2024
Q1 | $2.18M | Sell |
6,310
-479
| -7% | -$166K | ﹤0.01% | 694 |
|
|
2023
Q4 | $2.21M | Sell |
6,789
-3,368
| -33% | -$1.09M | ﹤0.01% | 689 |
|
|
2023
Q3 | $3.65M | Buy |
10,157
+579
| +6% | +$208K | 0.01% | 574 |
|
|
2023
Q2 | $3.64M | Buy |
9,578
+7,689
| +407% | +$2.92M | 0.01% | 584 |
|
|
2023
Q1 | $897K | Sell |
1,889
-96
| -5% | -$45.6K | ﹤0.01% | 809 |
|
|
2022
Q4 | $828K | Buy |
1,985
+480
| +32% | +$200K | ﹤0.01% | 807 |
|
|
2022
Q3 | $633K | Buy |
1,505
+75
| +5% | +$31.5K | ﹤0.01% | 861 |
|
|
2022
Q2 | $702K | Buy |
1,430
+279
| +24% | +$137K | ﹤0.01% | 856 |
|
|
2022
Q1 | $662K | Hold |
1,151
| – | – | ﹤0.01% | 863 |
|
|
2021
Q4 | $866K | Hold |
1,151
| – | – | ﹤0.01% | 832 |
|
|
2021
Q3 | $875K | Hold |
1,151
| – | – | ﹤0.01% | 832 |
|
|
2021
Q2 | $742K | Sell |
1,151
-68
| -6% | -$43.8K | ﹤0.01% | 856 |
|
|
2021
Q1 | $695K | Hold |
1,219
| – | – | ﹤0.01% | 843 |
|
|
2020
Q4 | $711K | Buy |
1,219
+5
| +0.4% | +$2.92K | ﹤0.01% | 807 |
|
|
2020
Q3 | $630K | Sell |
1,214
-1,086
| -47% | -$564K | ﹤0.01% | 780 |
|
|
2020
Q2 | $1.01M | Buy |
2,300
+1,318
| +134% | +$578K | ﹤0.01% | 796 |
|
|
2020
Q1 | $342K | Hold |
982
| – | – | ﹤0.01% | 853 |
|
|
2019
Q4 | $364K | Buy |
+982
| New | +$364K | ﹤0.01% | 897 |
|